Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Filings indexed 2,823 across all filing types
Latest filing 2017-11-14 Regulatory Filings
Country DK Denmark
Listing CO GMAB

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance
Regulatory Filings Classification · 85% confidence The text is a company press release announcing the first commercial sale milestone payment and an updated 2017 financial guidance. It does not contain actual financial statements, nor is it an earnings report, an annual or interim report, or any specific regulatory filing type. It is essentially a general corporate announcement that doesn’t fit other specialized categories, making it a fallback Regulatory Filing (RNS).
2017-11-14 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the total number of voting rights. This falls directly under the category of share capital changes or issues.
2017-11-14 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 90% confidence The document is a company announcement describing the exercise of employee warrants, the issuance of new shares in cash, the resulting increase in share capital, and updated total share count. This is clearly an announcement of a share issue/capital change rather than a financial report or regulatory filing. It directly pertains to a capital change event (new shares issued), matching the definition of Share Issue/Capital Change (Code: SHA).
2017-11-14 English
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'Company Announcement' and details a change in indirect ownership by a major shareholder (BlackRock, Inc.) crossing a threshold (5.03%). This type of filing, reporting changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). The text mentions the Danish Securities Trading Act, confirming it is a regulatory disclosure regarding shareholdings, not an earnings release (ER), annual report (10-K), or director's dealing (DIRS).
2017-11-09 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled 'Major Shareholder Announcement' and details a notification from BlackRock, Inc. regarding their acquisition of shares in Genmab A/S, crossing the 5% threshold of share capital and voting rights. This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2017-11-09 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report for the First Nine Months Ended September 30, 2017' and contains comprehensive financial statements, including income statements, balance sheets, cash flow statements, and management's discussion of financial performance. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.